fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Cells

Fonderflick L

The ATG8 Family Proteins GABARAP and GABARAPL1 Target Antigen to Dendritic Cells to Prime CD4 and CD8 T Cells.

2022

Advanced healthcare materials

Pierrevelcin M

Engineering Novel 3D Models to Recreate High-Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment.

2022

Cell death & disease

Kieu TL

Downregulation of Elovl5 promotes breast cancer metastasis through a lipid-droplet accumulation-mediated induction of TGF-β receptors.

2022

JAMA oncology

Conroy T

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.

2022

Cancers

El Baba R

Oncogenic and Stemness Signatures of the High-Risk HCMV Strains in Breast Cancer Progression.

2022

Pleura and peritoneum

Khellaf L

Peritoneal metastases of unknown primary with hepatoid features.

2022

Pharmacogenomics

Verdez S

Detection of relevant pharmacogenetic information through exome sequencing in oncology.

2022

Pharmaceuticals (Basel, Switzerland)

Dhaini B

Importance of Rose Bengal Loaded with Nanoparticles for Anti-Cancer Photodynamic Therapy.

2022

Clinical lung cancer

Mordant P

Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.

2022

Anti-cancer agents in medicinal chemistry

Toumi I

Anti-tumoral effect of Thymelaea hirsuta L. extracts in colorectal cancer cells.